Study: NCT02254447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 1
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan Cilexetil in formulation 2
Description: Round, biconvex white tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATACAND
Description: Round, biconvex pink tablets containing Candesartan cilexetil 16 mg for oral administration